 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Law Offices of Howard G. Smith reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Tandem Diabetes Care...

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)?Did you purchase your shares between August 3, 2022...

TANDEM DIABETES CARE, INC. (NASDAQ: TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc.

Glancy Prongay &amp; Murray LLP (GPM), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise...

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between...

Tandem Diabetes Care, Inc. (TNDM) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Tandem Diabetes Care, Inc. Securities Fraud Class Action

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Tandem Diabetes Care, Inc. (Tandem or the...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

Robbins Geller Rudman &amp; Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, both dates...

TNDM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ: TNDM) securities...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie s and Encourages Investors to Contact the Firm

TNDM INVESTOR ALERT: Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit TNDM INVESTOR ALERT: Tandem Diabetes Care, Inc. Investors with...

TNDM INVESTOR ALERT: Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Tandem...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action   TNDM

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

Watchers	14,158
52-Wk Low	$21.01
52-Wk High	$58.82

Market Cap	$1.48B
Volume (M)	259,791.00
52-Wk High	$58.82
52-Wk Low	$21.01

TNDM Tandem Diabetes Care Inc

About

Feed

News

Sentiment

Earnings

Fundamentals